Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 11741 | 894 | 33.9 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | FAMILIAL NON MEDULLARY THYROID CANCER | Author keyword | 6 | 80% | 0% | 4 |
| 2 | FAMILIAL THYROID CARCINOMA | Author keyword | 6 | 71% | 1% | 5 |
| 3 | CANC MOL GENET GEMOCA | Address | 4 | 75% | 0% | 3 |
| 4 | FAMILIAL NONMEDULLARY THYROID CARCINOMA | Author keyword | 4 | 75% | 0% | 3 |
| 5 | NONMEDULLARY THYROID CANCER | Author keyword | 4 | 75% | 0% | 3 |
| 6 | RADIAT EPIDEMIOL GRP | Address | 4 | 35% | 1% | 9 |
| 7 | FAMILIAL PAPILLARY THYROID CANCER | Author keyword | 3 | 100% | 0% | 3 |
| 8 | FAMILIAL PAPILLARY THYROID CARCINOMA | Author keyword | 3 | 100% | 0% | 3 |
| 9 | FOXE1 | Author keyword | 3 | 35% | 1% | 7 |
| 10 | GENET CANC SUSCEPTIBIL | Address | 3 | 60% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FOXE1 | 21 | 90% | 1% | 9 |
| 2 | WARRANTS AGGRESSIVE TREATMENT | 19 | 68% | 2% | 17 |
| 3 | EMERGING ENTITY | 14 | 64% | 2% | 14 |
| 4 | MNG1 | 14 | 100% | 1% | 7 |
| 5 | 19P132 | 11 | 100% | 1% | 6 |
| 6 | HORMONAL FACTORS | 10 | 26% | 4% | 32 |
| 7 | ANTHROPOMETRIC FACTORS | 5 | 25% | 2% | 17 |
| 8 | CELL OXYPHILIA | 4 | 67% | 0% | 4 |
| 9 | NUCLEAR BOMB TESTS | 4 | 75% | 0% | 3 |
| 10 | MULTICENTER SERIES | 4 | 40% | 1% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The changing epidemiology of thyroid cancer: why is incidence increasing? | 2015 | 3 | 20 | 70% |
| Obesity and Thyroid Cancer: A Clinical Update | 2014 | 10 | 53 | 66% |
| BMI, Diet and Female Reproductive Factors as Risks for Thyroid Cancer: A Systematic Review | 2012 | 28 | 46 | 80% |
| Familial Nonmedullary Thyroid Carcinoma | 2013 | 11 | 51 | 78% |
| Estrogen and its role in thyroid cancer | 2014 | 8 | 102 | 37% |
| Increasing world incidence of thyroid cancer: Increased detection or higher radiation exposure? | 2010 | 37 | 39 | 36% |
| Changing patterns in the incidence and survival of thyroid cancer with follicular phenotype - Papillary, follicular, and anaplastic: A morphological and epidemiological study | 2007 | 65 | 14 | 36% |
| Clinical Behavior and Genetics of Nonsyndromic, Familial Nonmedullary Thyroid Cancer | 2013 | 3 | 31 | 74% |
| Thyroid cancer gender disparity | 2010 | 35 | 56 | 34% |
| Is there really an increased incidence of thyroid cancer? | 2014 | 4 | 17 | 41% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CANC MOL GENET GEMOCA | 4 | 75% | 0.3% | 3 |
| 2 | RADIAT EPIDEMIOL GRP | 4 | 35% | 1.0% | 9 |
| 3 | GENET CANC SUSCEPTIBIL | 3 | 60% | 0.3% | 3 |
| 4 | GEN EPIDEMIOL | 3 | 32% | 0.8% | 7 |
| 5 | BANCA DATI AIRTUM | 2 | 67% | 0.2% | 2 |
| 6 | HLTH MED SOCIAL SCI | 2 | 67% | 0.2% | 2 |
| 7 | LOMBARDIA CANC REGISTRY | 2 | 67% | 0.2% | 2 |
| 8 | UNIT U852 | 2 | 67% | 0.2% | 2 |
| 9 | REGISTRE CANC TARN | 2 | 40% | 0.4% | 4 |
| 10 | ENDOCRINE SURG PROGRAM | 2 | 33% | 0.4% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000205126 | CHRONIC LYMPHOCYTIC THYROIDITIS//LYMPHOCYTIC THYROIDITIS//ADVANCED TUMOR STAGE |
| 2 | 0.0000197182 | ERBA//COLLISION METASTASIS//ANTIBODIES TO THYROID PEROXIDASE |
| 3 | 0.0000170305 | CHERNOBYL//PEDIATRIC THYROID CANCER//CHERNOBYL NUCLEAR ACCIDENT |
| 4 | 0.0000133995 | DIIODOMETHYL P TOLYLSULFONE//THYROID CARCINOGENESIS//AMICAL |
| 5 | 0.0000133015 | DIFFERENTIATED THYROID CANCER//THYROGLOBULIN//DIFFERENTIATED THYROID CARCINOMA |
| 6 | 0.0000111535 | RET PTC//PAPILLARY THYROID CARCINOMA//HBME 1 |
| 7 | 0.0000094636 | ARLTS1//HERITABLE CANCER//FAMILIAL RISK |
| 8 | 0.0000085349 | ANAPLASTIC THYROID CANCER//ANAPLASTIC THYROID CARCINOMA//LENVATINIB |
| 9 | 0.0000075866 | THYROID NODULE//THYROID NODULES//FOLLICULAR NEOPLASM |
| 10 | 0.0000069291 | URINARY IODINE//IODINE DEFICIENCY//URINARY IODINE CONCENTRATION |